About this trial
This database will describe sitting postural control in wheelchair, as well as PW pain, and pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient with neuromuscular disease
Written informed consent (IC) obtained
Adult patients (> 18 years) Or
Adults under guardianship who has given theirs oral consent and guardian's consent obtained Or
Disqualifiers
None
Trial population
Patients with neuromuscular disease, using Wheelchair, seen in positioning consultation by N. Pellegrini and / or E. Dupitier
Trial design
Cohort
Prospective
Treatments tested in this trial
Cohorte
Other interventionAssessment of postural wheelchair disorders, as well as PW pain, and pressure ulcers associated with sitting
Treatment groups
Trial outcomes
Primary outcomes
Description of postural wheelchair disorders in the neuromuscular disease population
Measurement of Posture by the tool: Measurement of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score (0 = normal, 1 = mild, 2 = moderated and 3 = severe)
Secondary outcomes
Comparison of pain associated with using the wheelchair
Assessment of initial pain (before positioning equipment) and pain after positioning equipment. Pain is assessed by a Simple Verbal Scale or by a Visual Analog Scale (0 to 10) (0 = no pain and 10 is the strongest pain)
Assessment of the incidence of pressure ulcers associated with sitting in NMD
Observation of the topography and the stage of ulcers associated with sitting
Assessment of the proportion of technical postural aids prescribed for patients who accept the positioning equipment
Counts of the numbers of technical postural aids prescribed during consultation
Assessment of the technical postural aids efficacy
Comparison of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score before and after using of technical postural aids (0 = normal, 1 = mild, 2 = moderated and 3 = severe)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Groupement Hospitalier Intercommunal du Vexin
Lead sponsor
Association Française contre les Myopathies (AFM), Paris
Collaborator